I've seen a couple of notes from Israeli analysts covering Teva (therefore, we should of course take this with a grain of salt), and they expect Teva's generic Lovenox to be approved first.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.